Skip to main content

Advertisement

Log in

Outcomes and costs with the introduction of robotic-assisted thoracic surgery in public hospitals

  • Research
  • Published:
Journal of Robotic Surgery Aims and scope Submit manuscript

Abstract

Robotic-assisted thoracic surgery (RATS) is an effective treatment of non-small cell lung cancer (NSCLC) but the effects of its implementation in university hospital networks has not been described. We analyzed the early clinical outcomes, estimated costs, and revenues associated with three robotic systems implemented in the Paris Public Hospital network. A retrospective study included patients who underwent RATS for NSCLC in 2019 and 2020. Ninety-day morbidity, mortality, hospital costs, and hospital revenues were described. Economic analyses were conducted either from the hospital center or from the French health insurance system perspectives. Cost drivers were tested using univariate and multivariable analyses. Sensitivity analyses were performed to assess uncertainty over in-hospital length of stay (LOS), number of robotic surgeries per year, investment cost, operating room occupancy time, maintenance cost, and commercial discount. The study included 188 patients (65.8 ± 9.3 years; Charlson 4.1 ± 1.4; stage I 76.6%). Median in-hospital LOS was 6 days [5–9.5], 90-day mortality was 1.6%. Mean hospital expenses and revenues were €12,732 ± 4914 and €11,983 ± 5708 per patient, respectively. In multivariable analysis, factors associated with hospital costs were body mass index, DLCO, major complications, and transfer to intensive care unit. Sensitivity analyses showed that in-hospital LOS (€11,802-€15,010) and commercial discounts on the list price (€11,458-€12,732) had an important impact on costs. During the first 2 years following the installation of three robotic systems in Paris Public Hospitals, the clinical outcomes of RATS for NSCLC have been satisfactory. Without commercial discount, hospital expenses would have exceeded hospital revenues.

Clinical registration number CNIL, N°2221601, CERC-SFCTCV-2021-07-20–Num17_MOPI_robolution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Availability of data

The data that support the findings of this study are available on request from the corresponding author, [H.I.].

References

  1. Ng CSH, MacDonald JK, Gilbert S et al (2019) Optimal approach to lobectomy for non-small cell lung cancer: systemic review and meta-analysis. Innovations (Phila) 14(2):90–116. https://doi.org/10.1177/1556984519837027

    Article  PubMed  Google Scholar 

  2. Aiolfi A, Nosotti M, Micheletto G et al (2021) Pulmonary lobectomy for cancer: systematic review and network meta-analysis comparing open, video-assisted thoracic surgery, and robotic approach. Surgery 169(2):436–446. https://doi.org/10.1016/j.surg.2020.09.010

    Article  PubMed  Google Scholar 

  3. Yang MZ, Lai RC, Abbas AE et al (2021) Learning curve of robotic portal lobectomy for pulmonary neoplasms: a prospective observational study. Thorac Cancer 12(9):1431–1440. https://doi.org/10.1111/1759-7714.13927

    Article  PubMed  PubMed Central  Google Scholar 

  4. Husereau D, Drummond M, Petrou S et al (2013) Consolidated health economic evaluation reporting standards (CHEERS)–explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health 16(2):231–250. https://doi.org/10.1016/j.jval.2013.02.002

    Article  PubMed  Google Scholar 

  5. Gonde H, Laurent M, Gillibert A et al (2017) The affordability of minimally invasive procedures in major lung resection: a prospective study. Interact Cardiovasc Thorac Surg 25(3):469–475. https://doi.org/10.1093/icvts/ivx149

    Article  PubMed  Google Scholar 

  6. Mederos MA, Jacob RL, Ward R et al (2022) Trends in robot-assisted procedures for general surgery in the veterans health administration. J Surg Res 279:788–795. https://doi.org/10.1016/j.jss.2022.06.055

    Article  PubMed  Google Scholar 

  7. Berna P, Quesnel C, Assouad J et al (2021) Guidelines on enhanced recovery after pulmonary lobectomy. Anaesth Crit Care Pain Med 40(1):100791. https://doi.org/10.1016/j.accpm.2020.100791

    Article  PubMed  Google Scholar 

  8. Agzarian J, Fahim C, Shargall Y et al (2016) The use of robotic-assisted thoracic surgery for lung resection: a comprehensive systematic review. Semin Thorac Cardiovasc Surg 28(1):182–192. https://doi.org/10.1053/j.semtcvs.2016.01.004

    Article  PubMed  Google Scholar 

  9. Agzarian J, Bessissow A, Srinathan S et al (2018) The effect of colchicine administration on postoperative pleural effusion following lung resection: a randomized blinded placebo-controlled feasibility pilot study. Eur J Cardiothorac Surg 53(4):822–827. https://doi.org/10.1093/ejcts/ezx401

    Article  PubMed  Google Scholar 

  10. Le Gac C, Gonde H, Gillibert A et al (2020) Medico-economic impact of robot-assisted lung segmentectomy: what is the cost of the learning curve? Interact Cardiovasc Thorac Surg 30(2):255–262. https://doi.org/10.1093/icvts/ivz246

    Article  PubMed  Google Scholar 

  11. Shanahan B, Kreaden US, Sorensen J et al (2022) Is robotic lobectomy cheaper? A micro-cost analysis. J Robot Surg 16(6):1441–1450. https://doi.org/10.1007/s11701-022-01377-x

    Article  PubMed  PubMed Central  Google Scholar 

  12. Paul S, Jalbert J, Isaacs AJ et al (2014) Comparative effectiveness of robotic-assisted vs thoracoscopic lobectomy. Chest 146(6):1505–1512. https://doi.org/10.1378/chest.13-3032

    Article  PubMed  Google Scholar 

  13. Swanson SJ, Miller DL, McKenna RJ Jr et al (2014) Comparing robot-assisted thoracic surgical lobectomy with conventional video-assisted thoracic surgical lobectomy and wedge resection: results from a multihospital database (premier). J Thorac Cardiovasc Surg 147(3):929–937. https://doi.org/10.1016/j.jtcvs.2013.09.046

    Article  PubMed  Google Scholar 

  14. Nasir BS, Bryant AS, Minnich DJ et al (2014) Performing robotic lobectomy and segmentectomy: cost, profitability, and outcomes. Ann Thorac Surg 98(1):203–208. https://doi.org/10.1016/j.athoracsur.2014.02.051. (discussion 08-9)

    Article  PubMed  Google Scholar 

  15. Patel MN, Hemal AK (2018) Does advancing technology improve outcomes? Comparison of the Da Vinci Standard/S/Si to the Xi robotic platforms during robotic nephroureterectomy. J Endourol 32(2):133–138. https://doi.org/10.1089/end.2017.0477

    Article  PubMed  Google Scholar 

  16. Guo F, Ma D, Li S (2019) Compare the prognosis of Da Vinci robot-assisted thoracic surgery (RATS) with video-assisted thoracic surgery (VATS) for non-small cell lung cancer: a meta-analysis. Medicine (Baltimore) 98(39):e17089. https://doi.org/10.1097/MD.0000000000017089

    Article  PubMed  Google Scholar 

  17. Ojima T, Nakamura M, Hayata K et al (2021) Comparison of short-term surgical outcomes using da Vinci S, Si and Xi Surgical System for robotic gastric cancer surgery. Sci Rep 11(1):11063. https://doi.org/10.1038/s41598-021-90741-2

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kneuertz PJ, Singer E, D’Souza DM et al (2019) Postoperative complications decrease the cost-effectiveness of robotic-assisted lobectomy. Surgery 165(2):455–460. https://doi.org/10.1016/j.surg.2018.08.024

    Article  PubMed  Google Scholar 

  19. Heiden BT, Mitchell JD, Rome E et al (2022) Cost-Effectiveness analysis of robotic-assisted lobectomy for non-small cell lung cancer. Ann Thorac Surg 114(1):265–272. https://doi.org/10.1016/j.athoracsur.2021.06.090

    Article  PubMed  Google Scholar 

  20. Patel YS, Hanna WC, Fahim C et al (2022) RAVAL trial: Protocol of an international, multi-centered, blinded, randomized controlled trial comparing robotic-assisted versus video-assisted lobectomy for early-stage lung cancer. PLoS ONE 17(2):e0261767. https://doi.org/10.1371/journal.pone.0261767

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None declared.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Lea BETSER, Pierre MORDANT, Alicia LE BRAS, Isabelle DURAND-ZALESKI, and Harry ETIENNE. The first draft of the manuscript was written by Lea BETSER and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Pierre Mordant.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 9 kb)

Supplementary file2 (DOCX 13 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Betser, L., Le Bras, A., Etienne, H. et al. Outcomes and costs with the introduction of robotic-assisted thoracic surgery in public hospitals. J Robotic Surg 18, 124 (2024). https://doi.org/10.1007/s11701-024-01879-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11701-024-01879-w

Keywords

Navigation